Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored Smoking Cessation Based on Response and Genotype (ConNic3)
NCT00894166Phase 3Completed
- Sponsor
- Duke University
- Start
- May 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion, varenicline + nicotine patch in nicotine dependence, sponsored by Duke University. Started May 2009; status: completed.
02
Drugs
bupropionvarenicline + nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00894166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894166.